TSBX
COM:TURNSTONEBIO
Turnstone Biologics
- Stock
Last Close
0.53
08/11 21:00
Market Cap
55.51M
Beta: -
Volume Today
213.22K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '22 | Jun '22 | Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | Mar '24 | Jun '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -12.62M - | 11.60M 191.95% | -16.15M 239.23% | -13.67M 15.38% | 68K 100.50% | -21.50M 31,716.18% | -17.32M 19.44% | -16.45M 5.02% | -19.63M 19.33% | ||
depreciation and amortization | 711K - | 932K 31.08% | 1.07M 15.13% | 1.19M 10.44% | 709K 40.17% | 730K 2.96% | 700K 4.11% | 659K 5.86% | 509K 22.76% | ||
deferred income tax | 346K - | 1.15M 232.95% | 5.52M 378.91% | 501K 90.92% | 577K 15.17% | 285K 50.61% | 1.21M 325.26% | -59K 104.87% | |||
stock based compensation | 962K - | 2.07M 115.49% | 1.19M 42.69% | 2.20M 84.85% | 992K 54.83% | 1.07M 8.27% | 1.06M 0.93% | 1.09M 2.07% | 1.05M 3.68% | ||
change in working capital | -5.97M - | -38.91M 552.09% | -3.61M 90.73% | -9.48M 162.78% | -19.26M 103.14% | 4.93M 125.60% | -3.80M 177.14% | 211K 105.55% | |||
accounts receivables | 855K - | 241K 71.81% | 1.18M 389.63% | -4.29M 463.47% | 4.25M 198.97% | 4.23M 0.28% | 33K 99.22% | 23K 30.30% | 194K 743.48% | ||
inventory | -1.18M - | -4.65M 293.81% | 1.23M 126.53% | -1.67M 235.36% | -1.56M 6.59% | ||||||
accounts payables | -780K - | 1.79M 329.74% | -239K 113.34% | 2.63M 1,202.09% | -2.64M 200.23% | -597K 77.39% | 2.19M 466.00% | -2.35M 207.41% | 1.39M 159.10% | ||
other working capital | -4.86M - | -36.30M 646.52% | -5.78M 84.07% | -6.16M 6.49% | -19.31M 213.56% | 1.29M 106.71% | -6.02M 565.02% | 2.54M 142.10% | |||
other non cash items | 109K - | 67K 38.53% | -32K 147.76% | -242K 656.25% | -256K 5.79% | -212K 17.19% | -640K 201.89% | -951K 48.59% | |||
net cash provided by operating activities | -16.45M - | -23.09M 40.30% | -12.01M 47.96% | -19.51M 62.39% | -17.17M 11.98% | -14.69M 14.44% | -18.79M 27.88% | -15.50M 17.47% | -17.46M 12.62% | ||
investments in property plant and equipment | -613K - | -2.15M 250.24% | -2.31M 7.50% | -102K 95.58% | -880K 762.75% | -110K 87.50% | -259K 135.45% | -144K - | |||
acquisitions net | |||||||||||
purchases of investments | -13.11M - | -11.22M 14.39% | -29.84M 165.98% | -5.35M 82.08% | -15.23M - | -62.24M 308.73% | -32.33M 48.06% | -6.76M 79.09% | |||
sales maturities of investments | 13M - | 10.50M 19.23% | 15M 42.86% | 11.25M 25% | 17.25M 53.33% | 18.25M 5.80% | 20.25M 10.96% | 26.75M 32.10% | 21M 21.50% | ||
other investing activites | 130K - | 63K 51.54% | -13K 120.63% | 272K 2,192.31% | |||||||
net cash used for investing activites | -718K - | -2.87M 299.16% | -17.15M 498.33% | 5.80M 133.82% | 16.50M 184.48% | 2.98M 81.97% | -42.26M 1,520.61% | -5.30M 87.45% | 14.10M 365.69% | ||
debt repayment | |||||||||||
common stock issued | -179K - | ||||||||||
common stock repurchased | |||||||||||
dividends paid | |||||||||||
other financing activites | -815K - | -266K 67.36% | 78.30M 29,534.59% | 10K 99.99% | |||||||
net cash used provided by financing activities | 10K - | 140K 1,300% | -2.81M 2,107.86% | 5K 100.18% | -815K 16,400% | -266K 67.36% | 78.30M 29,534.59% | -169K 100.22% | |||
effect of forex changes on cash | |||||||||||
net change in cash | -17.16M - | -25.81M 50.39% | -31.97M 23.86% | -13.70M 57.14% | -1.49M 89.16% | -11.98M 706.87% | 17.25M 243.93% | -20.98M 221.64% | -3.37M 83.96% | ||
cash at beginning of period | 123.76M - | 106.60M 13.87% | 80.79M 24.21% | 48.82M 39.58% | 35.11M 28.07% | 33.63M 4.23% | 21.65M 35.63% | 38.89M 79.67% | 17.91M 53.94% | ||
cash at end of period | 106.60M - | 80.79M 24.21% | 48.82M 39.58% | 35.11M 28.07% | 33.63M 4.23% | 21.65M 35.63% | 38.89M 79.67% | 17.91M 53.94% | 14.55M 18.78% | ||
operating cash flow | -16.45M - | -23.09M 40.30% | -12.01M 47.96% | -19.51M 62.39% | -17.17M 11.98% | -14.69M 14.44% | -18.79M 27.88% | -15.50M 17.47% | -17.46M 12.62% | ||
capital expenditure | -613K - | -2.15M 250.24% | -2.31M 7.50% | -102K 95.58% | -880K 762.75% | -110K 87.50% | -259K 135.45% | -144K - | |||
free cash flow | -17.07M - | -25.23M 47.84% | -14.32M 43.24% | -19.61M 36.93% | -18.05M 7.96% | -14.80M 18% | -19.05M 28.68% | -15.50M 18.60% | -17.60M 13.54% |
All numbers in (except ratios and percentages)